Does Wearing-Off of Efficacy Occur in Galcanezumab-Treated Patients at the End of the Monthly Treatment Cycle: A Post Hoc Analysis of Four Phase 3 Randomized Trials

被引:0
|
作者
Ailani, Jessica [1 ]
Kuruppu, Dulanji [2 ]
Rettiganti, Mallikarjuna [2 ]
Oakes, Tina [2 ]
Wietecha, Linda [2 ]
Port, Martha [2 ]
Blumenfeld, Andrew [3 ]
机构
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Neurol Ctr Southern Calif, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1922
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Virginia L. Stauffer
    Ira Turner
    Phebe Kemmer
    William Kielbasa
    Kathleen Day
    Martha Port
    Tonya Quinlan
    Angelo Camporeale
    The Journal of Headache and Pain, 2020, 21
  • [32] Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
    Eder, Lihi
    Gladman, Dafna
    Aydin, Sibel
    Ogdie, Alexis
    Shi, Harry
    Landry, Pierre-Alexandre
    Luna, Rayana
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1043 - 1044
  • [33] Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
    Eder, Lihi
    Gladman, Dafna
    Aydin, Sibel Zehra
    Ogdie, Alexis
    Shi, Harry
    Landry, Pierre-Alexandre
    Luna, Rayana
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] A POST HOC ANALYSIS OF FACTORS ASSOCIATED WITH SIGNIFICANT REDUCTION IN MIGRAINE HEADACHE DAYS FROM THREE PHASE 3 PLACEBO-CONTROLLED TRIALS OF PATIENTS WITH EPISODIC AND CHRONIC MIGRAINE TREATED WITH GALCANEZUMAB
    Aurora, S. K.
    Ruff, D. D.
    Zhang, Q.
    Pearlman, E. M.
    CEPHALALGIA, 2018, 38 : 81 - 82
  • [35] Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
    Conaghan, Philip G.
    Pavelka, Karel
    Hsieh, Song-Chou
    Bonnington, Terri-Leigh
    Kent, Toby C.
    Marchbank, Katie
    Edwards, Christopher J.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
  • [36] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, P. J.
    Kavanaugh, A.
    Gladman, D. D.
    Fitzgerald, O.
    Soriano, E.
    Nash, P.
    Feng, D.
    Lertratanakul, A.
    Douglas, K.
    Lippe, R.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1294 - 1295
  • [37] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [38] CHARACTERIZATION OF REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH UPADACITINIB: POST-HOC ANALYSIS FROM TWO PHASE 3 TRIALS
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    Fitzgerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinva
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laura
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 45 - 45
  • [39] Characterization of Remission in Patients with Psoriatic Arthritis Treated with Upadacitinib: Post-hoc Analysis from Two Phase 3 Trials
    Gladman, Dafna
    Kavanaugh, Arthur
    FitzGerald, Oliver
    Soriano, Enrique
    Nash, Peter
    Feng, Dai
    Lertratanakul, Apinya
    Douglas, Kevin
    Lippe, Ralph
    Gossec, Laure
    Mease, Philip
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1115 - 1115
  • [40] Anamorelin in Cachectic Patients with Advanced NSCLC, a Post-Hoc Pooled Efficacy Data Analysis of Two Phase 3 Trials
    Currow, David
    Teme, Jennifer
    Abernethy, Amy
    Friend, John
    Fearons, Kenneth
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S665 - S666